Jay Mazel, MD
Clinical Cardiac Electrophysiology · Washington, DCNPI 1851308704
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,875 of the $18,203 with a category attached, or 76.2%. 11 manufacturers reported payments, led by Biosense Webster, Inc. at 42.4% of the total. Reporting peaked in 2023 at $8,368 and has fallen 67.2% since, to $2,743 in 2025.
Across 259 payments — averaging $70.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$8K
- Medical Device Business Services, Inc.$8K
- Medtronic$2K
- Atricure, Inc.$145
- Abbott$116
- Cardiva Medical, Inc.$113
- plus $173 from 5 others
What the payments were for
- Consulting fees$13,87576%
- Travel & lodging$1901%
- Food & beverage$4,13723%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 41 | $7,721 |
| Medical Device Business Services, Inc. | 5 | $7,500 |
| Medtronic(2 entities) | 193 | $2,435 |
| Atricure, Inc. | 1 | $145 |
| Abbott | 8 | $116 |
| Cardiva Medical, Inc. | 4 | $113 |
| AstraZeneca | 3 | $77 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Novartis | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical cardiac electrophysiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 252 | $375,825 |
| MultaqDronedarone Hcl | 58 | $73,066 |
| XareltoRivaroxaban | 45 | $59,184 |
| Dofetilide | 56 | $27,408 |
| Amiodarone Hcl | 93 | $7,723 |
| Propafenone Hcl ErPropafenone Hcl | 19 | $5,583 |
| Metoprolol Succinate | 210 | $4,407 |
| Flecainide Acetate | 63 | $1,847 |
| SotalolSotalol Hcl | 50 | $1,202 |
| Rosuvastatin Calcium | 29 | $659 |
| Atorvastatin Calcium | 39 | $565 |
| Losartan Potassium | 24 | $348 |
| Amlodipine Besylate | 25 | $292 |
| Pantoprazole Sodium | 18 | $226 |
| Pravastatin Sodium | 11 | $145 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Washington
- Manish ShahWashington$430K
- Zayd EldadahWashington$358K
- Allen SolomonWashington$142K
- Rajiv KabadiWashington$82K
- Apostolos TsimploulisWashington$28K
- Rohan PatelWashington$20K
- Marco MercaderWashington$11K
- Marco CavagnaWashington$5K
- Hans MooreWashington$4K
- Allison WarrenWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.